Somapacitan, a once-weekly reversible albumin-binding GH derivative, in children with GH deficiency: A randomized dose-escalation trial.

about

Growth Hormone Research Society perspective on biomarkers of GH action in children and adults.Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial.

P2860

Q52684487-C913976D-CFE6-4B60-AEB9-4108FB7F9F76 Q52808668-3482B78F-CB99-41EB-982F-AF0A2F506020

P2860

Somapacitan, a once-weekly reversible albumin-binding GH derivative, in children with GH deficiency: A randomized dose-escalation trial.

Item

http://www.wikidata.org/entity/Q48213660

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Somapacitan, a once-weekly rev ...... domized dose-escalation trial.

@en

Somapacitan, a once-weekly rev ...... domized dose-escalation trial.

@nl

type

Item

label

Somapacitan, a once-weekly rev ...... domized dose-escalation trial.

@en

Somapacitan, a once-weekly rev ...... domized dose-escalation trial.

@nl

prefLabel

Somapacitan, a once-weekly rev ...... domized dose-escalation trial.

@en

Somapacitan, a once-weekly rev ...... domized dose-escalation trial.

@nl

P1476

Somapacitan, a once-weekly rev ...... domized dose-escalation trial.

@en

P2093

Jean De Schepper

http://www.w3.org/2001/XMLSchema#string

NN8640-4042 Study Group

http://www.w3.org/2001/XMLSchema#string

Nehama Zuckerman-Levin

http://www.w3.org/2001/XMLSchema#string

Zoran Gucev

http://www.w3.org/2001/XMLSchema#string

P2860

GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults.

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations

A long-acting human growth hormone with delayed clearance (VRS-317): results of a double-blind, placebo-controlled, single ascending dose study in growth hormone-deficient adults

Non-compliance with growth hormone treatment in children is common and impairs linear growth.

A Randomized Safety and Efficacy Study of Somavaratan (VRS-317), a Long-Acting rhGH, in Pediatric Growth Hormone Deficiency

Reversible Albumin-Binding GH Possesses a Potential Once-Weekly Treatment Profile in Adult Growth Hormone Deficiency.

Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes.

A multicenter study of the efficacy and safety of sustained release GH in the treatment of naive pediatric patients with GH deficiency.

Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety.

P304

350-358

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CEN.13409

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tadej Battelino

Lars Sävendahl

Michael Højby Rasmussen

P577

2017-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28656605

http://www.w3.org/2001/XMLSchema#string

Somapacitan, a once-weekly reversible albumin-binding GH derivative, in children with GH deficiency: A randomized dose-escalation trial.

about

P2860

P2860

Somapacitan, a once-weekly reversible albumin-binding GH derivative, in children with GH deficiency: A randomized dose-escalation trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698